NASDAQ:YTEN

Yield10 Bioscience (YTEN) Stock Forecast, Price & News

$2.78

-0.06 (-2.11%)

(As of 12:44 PM ET)

Compare

Today's Range: $2.78
▼
$2.85
50-Day Range: $2.50
▼
$3.19
52-Week Range: $1.63
▼
$4.19

Volume: 6,423 shs
Average Volume: 171,241 shs
Market Capitalization: $16.74 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Yield10 Bioscience MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
1.95% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
$999,999 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($1.84) to ($0.78) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.78 out of 5 stars

Consumer Staples Sector

104th out of 140 stocks

Agricultural Production - Crops Industry

9th out of 11 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Yield10 Bioscience.

5.0

Short Interest

Percentage of Shares Shorted
1.95% of the float of Yield10 Bioscience has been sold short.
Short Interest Ratio / Days to Cover
Yield10 Bioscience has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Yield10 Bioscience has recently decreased by 27.78%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Yield10 Bioscience does not currently pay a dividend.
Dividend Growth
Yield10 Bioscience does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for YTEN.

2.8

News and Social Media Coverage

News Sentiment
Yield10 Bioscience has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Consumer Staples companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Yield10 Bioscience this week, compared to 1 article on an average week.
Search Interest
Only 4 people have searched for YTEN on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
1 people have added Yield10 Bioscience to their MarketBeat watchlist in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Yield10 Bioscience insiders have bought more of their company's stock than they have sold. Specifically, they have bought $999,999.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 5.30% of the stock of Yield10 Bioscience is held by insiders.
Percentage Held by Institutions
Only 7.69% of the stock of Yield10 Bioscience is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Yield10 Bioscience are expected to grow in the coming year, from ($1.84) to ($0.78) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Yield10 Bioscience is -0.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Yield10 Bioscience is -0.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Yield10 Bioscience has a P/B Ratio of 14.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Yield10 Bioscience (NASDAQ:YTEN) Stock

Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company was founded by Anthony J. Sinskey, Simon F. Williams, and Oliver P. Peoples in 1992 and is headquartered in Woburn, MA.

Receive YTEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter.

YTEN Stock News Headlines

May 29, 2023 | americanbankingnews.com

Yield10 Bioscience, Inc. (NASDAQ:YTEN) Short Interest Update

May 16, 2023 | americanbankingnews.com

HC Wainwright Weighs in on Yield10 Bioscience, Inc.'s Q2 2023 Earnings (NASDAQ:YTEN)

June 2, 2023 | Edge On The Street (Ad)

Is Graphite the New Lithium?

Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.

May 15, 2023 | americanbankingnews.com

Reviewing Yield10 Bioscience (NASDAQ:YTEN) & Edible Garden (NASDAQ:EDBL)

May 13, 2023 | americanbankingnews.com

Yield10 Bioscience, Inc. to Post FY2027 Earnings of $0.10 Per Share, HC Wainwright Forecasts (NASDAQ:YTEN)

May 12, 2023 | insidermonkey.com

Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q1 2023 Earnings Call Transcript

May 12, 2023 | finanznachrichten.de

Yield10 Bioscience, Inc.: Yield10 Bioscience Announces First Quarter 2023 Financial Results

May 12, 2023 | msn.com

HC Wainwright & Co. Reiterates Yield10 Bioscience (YTEN) Buy Recommendation

June 2, 2023 | Edge On The Street (Ad)

The Graphite Shortage Story You're Not Being Told

Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.

May 12, 2023 | markets.businessinsider.com

Maxim Group Remains a Buy on Yield10 Bioscience (YTEN)

May 11, 2023 | markets.businessinsider.com

Lake Street Sticks to Its Buy Rating for Yield10 Bioscience (YTEN)

May 11, 2023 | americanbankingnews.com

Yield10 Bioscience, Inc. (NASDAQ:YTEN) Major Shareholder Purchases $999,998.60 in Stock

May 10, 2023 | msn.com

Yield10 Bioscience: Q1 Earnings Insights

May 10, 2023 | finance.yahoo.com

Yield10 Bioscience Announces First Quarter 2023 Financial Results

May 9, 2023 | msn.com

Yield10 Bioscience's Earnings Outlook

May 9, 2023 | americanbankingnews.com

Yield10 Bioscience (YTEN) Scheduled to Post Quarterly Earnings on Wednesday

May 8, 2023 | americanbankingnews.com

Analyzing Yield10 Bioscience (NASDAQ:YTEN) & Fresh Del Monte Produce (NYSE:FDP)

May 5, 2023 | marketwatch.com

8-K: YIELD10 BIOSCIENCE, INC.

May 4, 2023 | finance.yahoo.com

Yield10 Bioscience to Announce First Quarter 2023 Financial Results and Host a Conference Call on Wednesday, May 10, 2023

May 3, 2023 | finance.yahoo.com

Yield10 Bioscience Announces Pricing of $3.0 Million Registered Direct Offering and Concurrent Private Placement

May 2, 2023 | americanbankingnews.com

AMAYA Global (OTCMKTS:AYAG) versus Yield10 Bioscience (NASDAQ:YTEN) Head-To-Head Comparison

May 1, 2023 | marketwatch.com

Yield10 Bioscience Shares Rise 14% After Possible Investment By Marathon Petroleum

May 1, 2023 | tmcnet.com

Yield10 Bioscience and Marathon Petroleum Corporation Sign LOI

May 1, 2023 | msn.com

Yield10 Bioscience inks LOI for potential investment, offtake deal with Marathon

April 29, 2023 | americanbankingnews.com

Short Interest in Yield10 Bioscience, Inc. (NASDAQ:YTEN) Drops By 13.6%

April 23, 2023 | americanbankingnews.com

Yield10 Bioscience (NASDAQ:YTEN) Stock Crosses Above 200-Day Moving Average of $2.76

April 2, 2023 | americanbankingnews.com

Financial Analysis: Origin Agritech (NASDAQ:SEED) & Yield10 Bioscience (NASDAQ:YTEN)

See More Headlines

YTEN Price History

30 days | 90 days | 365 days | Advanced Chart

YTEN Company Calendar

Last Earnings: 3/14/2023
Today: 6/02/2023
Next Earnings (Estimated): 8/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Agricultural production - crops
Sub-Industry: N/A
Sector: Consumer Staples
Current Symbol: NASDAQ:YTEN
CUSIP: N/A
CIK: 1121702
Web: www.yield10bio.com
Phone: (617) 583-1700
Fax: 617-583-1768
Employees: 29
Year Founded: 1992

Profitability

EPS (Most Recent Fiscal Year): ($2.84)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-13,570,000.00
Net Margins: -3,882.82%
Pretax Margin: -3,842.10%
Return on Equity: -243.41%
Return on Assets: -143.90%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.08
Quick Ratio: 1.08

Sales & Book Value

Annual Sales: $450,000.00
Price / Sales: 37.99
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.19 per share
Price / Book: 14.95

Miscellaneous

Outstanding Shares: 6,020,000
Free Float: 5,701,000
Market Cap: $17.10 million
Optionable: Not Optionable
Beta: 1.81

Social Links

Key Executives

Oliver P. Peoples
President, Chief Executive Officer & Director

Charles B. Haaser
Chief Accounting Officer, Treasurer & VP-Finance

Kristi D. Snell
Chief Science Officer & Vice President-Research

Nicholas Renegar
Director-Business Analytics & Operations

Lynne H. Brum
Secretary, VP-Planning & Communications

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

YTEN Stock - Frequently Asked Questions

How have YTEN shares performed in 2023?: Yield10 Bioscience's stock was trading at $1.6695 at the beginning of the year. Since then, YTEN stock has increased by 70.1% and is now trading at $2.8399.
View the best growth stocks for 2023 here.
Are investors shorting Yield10 Bioscience?: Yield10 Bioscience saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 78,000 shares, a drop of 27.8% from the April 30th total of 108,000 shares. Based on an average daily volume of 43,600 shares, the days-to-cover ratio is currently 1.8 days. Currently, 2.0% of the shares of the company are short sold.
View Yield10 Bioscience's Short Interest.
When is Yield10 Bioscience's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our YTEN earnings forecast.
How were Yield10 Bioscience's earnings last quarter?: Yield10 Bioscience, Inc. (NASDAQ:YTEN) released its earnings results on Tuesday, March, 14th. The specialty chemicals company reported ($0.67) earnings per share for the quarter. The specialty chemicals company earned $0.09 million during the quarter. Yield10 Bioscience had a negative trailing twelve-month return on equity of 243.41% and a negative net margin of 3,882.82%.
When did Yield10 Bioscience's stock split?: Yield10 Bioscience's stock reverse split before market open on Thursday, January 16th 2020. The 1-40 reverse split was announced on Wednesday, January 15th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 15th 2020. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.
What other stocks do shareholders of Yield10 Bioscience own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Yield10 Bioscience investors own include KushCo (KSHB), OPKO Health (OPK), T2 Biosystems (TTOO), FuelCell Energy (FCEL), TherapeuticsMD (TXMD), Viking Therapeutics (VKTX), Rigel Pharmaceuticals (RIGL), Advanced Micro Devices (AMD).

What is Yield10 Bioscience's stock symbol?: Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN."
Who are Yield10 Bioscience's major shareholders?: Yield10 Bioscience's stock is owned by a variety of retail and institutional investors. Top institutional investors include Grand Wealth Management LLC (0.56%). Insiders that own company stock include Anthony J Sinskey, Charles B Haaser and Jack W Schuler.
View institutional ownership trends.
How do I buy shares of Yield10 Bioscience?: Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Yield10 Bioscience's stock price today?: One share of YTEN stock can currently be purchased for approximately $2.84.
How much money does Yield10 Bioscience make?: Yield10 Bioscience (NASDAQ:YTEN) has a market capitalization of $17.10 million and generates $450,000.00 in revenue each year. The specialty chemicals company earns $-13,570,000.00 in net income (profit) each year or ($2.84) on an earnings per share basis.
How can I contact Yield10 Bioscience?: Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The official website for the company is www.yield10bio.com. The specialty chemicals company can be reached via phone at (617) 583-1700, via email at brets@coreir.com, or via fax at 617-583-1768.

This page (NASDAQ:YTEN) was last updated on 6/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial